
Flisur 30mg/500mg Tablet ER
Marketer
Retra Life Science Pvt Ltd
Salt Composition
Gliclazide (30mg) + Metformin (500mg)
Overview Flisur 30mg/500mg Tablet ER
Diabex Duo 30mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to manage hypoglycemia. Alcohol consumption should be minimized due to its hypoglycemic effect. Other potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell count, liver function) are recommended.
Uses of Flisur 30mg/500mg Tablet ER
Adult-onset diabetes
Major Benefits of Flisur 30mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Flisur 30mg/500mg Extended-Release tablet without crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Flisur 30mg/500mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Dizziness
- Diarrhea
- Upper respiratory tract infection
- Nausea
- Flatulence
- Constipation
How to use Flisur 30mg/500mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Flisur 30mg/500mg Extended-Release tablet with food.
How Flisur 30mg/500mg Tablet ER works:
Extended-release Flisur tablets (30mg/500mg) contain gliclazide and metformin, a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Flisur 30mg/500mg Extended-Release Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Flisur 30mg/500mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Flisur 30mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Flisur 30mg/500mg Extended-Release tablets, potentially requiring dosage modification. Consult your physician for guidance. Flisur 30mg/500mg Extended-Release tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Flisur 30mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary for Flisur 30mg/500mg Extended-Release tablets in these patients. Medical advice is recommended. For individuals with mild to moderate hepatic dysfunction, Flisur 30mg/500mg Extended-Release tablets are typically initiated at a reduced dosage; however, it is contraindicated in those with severe liver disease.
What if you forget to take Flisur 30mg/500mg Tablet ER :
Should you forget to take your Flisur 30mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Flisur 30mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
